This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is NOT a primary trading bloc in the globalized economy? a. North and ... (Read 29 times)

Charlie

  • Hero Member
  • *****
  • Posts: 640
Which of the following is NOT a primary trading bloc in the globalized economy?
 
  a. North and South America, dominated by the U.S.
  b. Europe, dominated by Germany
  c. Asia, dominated by Japan and China
  d. Africa, dominated by Egypt

Question 2

Affirmative action began during the __________ administration.
 
  a. Kennedy
  b. Johnson
  c. Nixon
  d. Carter



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

stano32

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

d

Answer to Question 2

a




Charlie

  • Member
  • Posts: 640
Reply 2 on: Jul 2, 2018
Gracias!


nothere

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Excellent

 

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library